Diagnostic significance of the novel biomarker combination for early-stage non-small cell lung cancer detection: results of the blind clinical study

BackgroundNSCLC can be cured in up to 65% of cases if detected early. However, most of the lung cancer (LC) cases are diagnosed at an advanced stage.ObjectiveThe assessment of various tumor markers in retrospective double-blind clinical study and their possible combinations for detection of early-st...

Full description

Saved in:
Bibliographic Details
Main Authors: Janneta Tcherkassova, Evgueni Klinski, Sergey Tsurkan, Anna Prostyakova, Alexander Boroda, Yuliya N. Pirogova, Leonid N. Bagmet, Marina Sekacheva
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1508563/full
Tags: Add Tag
No Tags, Be the first to tag this record!